SWOG clinical trial number
SWOG-9127

Evaluation of Cisplatin, Carboplatin and Etoposide in Selected Stage IIIb and Stage IV Non-Small Cell Lung Carcinoma, Phase II

100% Accrual
Accrual
100%
Closed
Phase
100% Accrual
Accrual
100%
Published
Abbreviated Title
Evaluation of Cisplatin, Carboplatin and Etoposide in Selected Stage IIIb and Stage IV Non-Small Cell Lung Carcinoma, Phase II
Activated
08/01/1991
Closed
03/01/1992

Research committees

Lung Cancer

Other Clinical Trials

S2414
SWOG Clinical Trial Number

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)

Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
0% Accrual
Accrual
0%
Open
Phase
A082002
SWOG Clinical Trial Number

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer

Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
CTSU/NRG-LU007
SWOG Clinical Trial Number

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial

Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open